Being A Trusted Community Partner Spotlight: May 2024 Edition
Dear subscribers,
Welcome to our May 2024 edition! At MGI, we have diligently focused on advancing genomics technology to benefit everyone in our community, fostering cutting-edge scientific research as a reliable partner. This month, we reflect on milestones that underscore our commitment to this pivotal role.
Explore the key highlights from May:
Being A Trusted Partner to Our Community
At MGI, our objective is simple and clear: to benefit people globally with advanced life science technology. May marks significant achievements on our collective journey towards this noble aim.
We foster knowledge exchanges and drive frontier research to improve public health.
At the 8th International Genetic Disorder Conference, part of the globally acclaimed IFCC WorldLab 2024 Dubai Congress on May 26 to 30 in Dubai World Trade Centre, MGI hands with UAE Genetic Diseases Association ("UAEGDA") to foster knowledge exchanges and delve into the impact of genomics on public health improvement.
Dr. Mariam Mohamed Fatima Matar MD Phd , Founder and Chairperson of UAEGDA, shares her enthusiasm for partnership with MGI, highlighting the potential to leverage both strengths to promote accessibility of genomics technology.
MGI empowered Centre for Translational Stem Cell Biology ("CTSCB"), in the realm of stem cell technology research and applications. Professor Liu from CTSCB expressed his excitement about this partnership, emphasizing the joint efforts to drive scientific discoveries in the field of single-cell technology to improve human health.
MGI facilitates research on rare diseases and tumors at institutions like Juntendo University, ALACRiS Theranostics GmbH, KAUST (King Abdullah University of Science and Technology) to advance precision medicine. Uncover the full stories in our latest Ebook "Democratizing Precision Medicine".
We practice sustainable development.
Recently, MGI's sequencers DNBSEQ-G99 and DNBSEQ-T7 received the prestigious ISO 14067 Carbon Footprint Certificate from TÜV Rheinland Greater China. This certification underscores our advancements in measuring and controlling greenhouse gas emissions and highlights our commitment to sustainability.
We are dedicated to biodiversity conservation.
MGI supports the Biodiversity Plan actively by developing innovative tools, fostering global collaborations, and contributing to life science initiatives. More than 4,000 species genomes have been sequenced on our DNBSEQ platform, a record showcasing our footprints in biodiversity conservation.
Recommended by LinkedIn
As we forge ahead, MGI remains resolute in our commitment to being a trusted partner to our community, driving forward scientific advancements that not only push the boundaries of knowledge but also create a healthier, more sustainable world for all.
How MGI is at the Forefront of Frontier Science
What are MGI's key challenges facing global business expansion? How does MGI envision the future of genomics? Gain exclusive insights from Dr. Roy's in-depth interview featured in the May 2024 edition of PrecisionMed International Magazine.
Don't Miss Out: Upcoming Events
Visit us at Booth 524 to discover how MGI is empowering researchers worldwide. Click for more details on MGI's participation in the event.
Key figures in the field of oncology from around the world will convene to share new advancements and discuss ways to enhance our fight against cancer. Join us at booth 101!
Thank you for reading! Catch us next month and be sure to follow us on LinkedIn, X, and YouTube for more of the latest content from MGI. To get more information, please visit the MGI website.
Warmest regards,
The “MGI Newsletter” Editorial Team